A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer

H Ueno; T Kosuge; Y Matsuyama; J Yamamoto; A Nakao; S Egawa; R Doi; M Monden; T Hatori; M Tanaka; M Shimada; K Kanemitsu

首页> 外文期刊>British Journal of Cancer >A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer

【24h】

A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer

机译：一项吉西他滨与手术切除的胰腺癌患者比较的吉西他滨随机对照试验：日本胰腺癌辅助治疗研究小组

获取原文

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background:This multicentre randomised phase III trial was designed to determine whether adjuvant chemotherapy with gemcitabine improves the outcomes of patients with resected pancreatic cancer.

机译：背景：这项多中心随机III期试验旨在确定吉西他滨辅助化疗是否能改善胰腺癌切除患者的预后。

著录项

来源
《British Journal of Cancer 》 |2009年第6期| 共8页
作者
H Ueno; T Kosuge; Y Matsuyama; J Yamamoto; A Nakao; S Egawa; R Doi; M Monden; T Hatori; M Tanaka; M Shimada; K Kanemitsu;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学 ;
关键词

相似文献

外文文献
中文文献
专利

1. Randomized phase III trial of adjuvant chemotherapy with gemcitabine versus S-1 in patients with resected pancreatic cancer: Japan Adjuvant Study Group of Pancreatic Cancer (JASPAC-01). [J] . Maeda A, Boku N, Fukutomi A, Japanese journal of clinical oncology. . 2008 ,第3期

机译：胰腺癌切除术后吉西他滨与S-1辅助化疗的III期随机试验：日本胰腺癌辅助研究组（JASPAC-01）。
2. Randomized Phase III Trial of Adjuvant Chemotherapy with Gemcitabine versus S-1 in Patients with Resected Pancreatic Cancer: Japan Adjuvant Study Group of Pancreatic Cancer (JASPAC-01) [J] . Atsuyuki Maeda1 Narikazu Boku2 Akira Fukutomi2 Satoshi Kondo3 Taira Kinoshita4 Masato Nagino5 and Katsuhiko Uesaka1 Japanese Journal of Clinical Oncology . 2008 ,第3期

机译：吉西他滨与S-1联合化疗在胰腺癌切除患者中进行的III期随机对照试验：日本胰腺癌辅助研究组（JASPAC-01）
3. Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial [J] . Neoptolemos John P., Palmer Daniel H., Ghaneh Paula, The Lancet . 2017 ,第10073期

机译：佐剂吉西他滨与吉西他滨单药治疗患者的糖类吉西他滨（ESPAC-4）比较：多期，开放标签，随机，第3阶段试验
4. Adjuvant therapy for pancreatic cancer. [C] . Asma Sultana, Trevor Cox, Paula Ghaneh, St. Gallen EORTC Gastrointestinal Cancer Conference . 2012

机译：糖类治疗胰腺癌。
5. Assessment of "gene-environment" interaction in cases of familial pancreatic cancer as compared to cases of sporadic pancreatic cancer. [D] . Yeo, Theresa Pluth. 2007

机译：与散发性胰腺癌相比，评估家族性胰腺癌“基因-环境”相互作用。
6. A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer [O] . H Ueno, T Kosuge, Y Matsuyama, 2009

机译：一项吉西他滨与仅手术切除的胰腺癌患者比较的随机III期试验：日本胰腺癌辅助疗法研究小组
7. A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer [O] . Ueno, H, Kosuge, T, Matsuyama, Y, 2009

机译：一项吉西他滨与仅手术切除的胰腺癌患者比较的随机III期试验：日本胰腺癌辅助疗法研究小组

A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer

摘要

著录项

相似文献

相关主题

期刊订阅